Cargando…

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Cancer immunotherapy is a promising way to eliminate tumor cells by using the patient’s own immune system. Selecting the appropriate animal models to develop or validate preclinical immunotherapeutic trials is now an important aspect of many cancer research programs. Here we discuss the advantages a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Yunsik, Lee, Sanghyuk, Kim, Kapyoul, Kim, Soo-Hyun, Chung, Yeun-Jun, Lee, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082857/ https://www.ncbi.nlm.nih.gov/pubmed/30089794 http://dx.doi.org/10.1038/s12276-018-0115-0

Ejemplares similares

Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics
por: Guilhamon, Paul, et al.
Publicado: (2014)

Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines
por: Woo, Xing Yi, et al.
Publicado: (2019)

Establishment and Characterization of Patient-Derived Xenografts (PDXs) of Different Histology from Malignant Pleural Mesothelioma Patients
por: Affatato, Roberta, et al.
Publicado: (2020)

Validity of patient-derived xenograft mouse models for lung cancer based on exome sequencing data
por: Kim, Jaewon, et al.
Publicado: (2020)

Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse
por: du Manoir, Stanislas, et al.
Publicado: (2013)

Development of Personalized Therapeutic Strategies by Targeting Actionable Vulnerabilities in Metastatic and Chemotherapy-Resistant Breast Cancer PDXs
por: Punzi, Simona, et al.
Publicado: (2019)

Pyridoxal phosphate synthases PdxS/PdxT are required for Actinobacillus pleuropneumoniae viability, stress tolerance and virulence
por: Xie, Fang, et al.
Publicado: (2017)

Discovering Synergistic Compounds with BYL-719 in PI3K Overactivated Basal-like PDXs
por: Boyd, David C., et al.
Publicado: (2023)

Comparison of the Genetic Alterations between Primary Colorectal Cancers and Their Corresponding Patient-Derived Xenograft Tissues
por: Yu, Sang Mi, et al.
Publicado: (2018)

Protocol to generate a patient derived xenograft model of acquired resistance to immunotherapy in humanized mice
por: Martínez-Sabadell, Alex, et al.
Publicado: (2022)

Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies
por: Kleinmanns, Katrin, et al.
Publicado: (2022)

Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma
por: Yan, Chi, et al.
Publicado: (2023)

Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs
por: Reddy, Tejaswini P., et al.
Publicado: (2020)

Development of humanized mouse with patient‐derived xenografts for cancer immunotherapy studies: A comprehensive review
por: Jin, Ke‐Tao, et al.
Publicado: (2021)

Development of a patient-derived xenograft model of glioblastoma via intravitreal injection in mice
por: Lee, Jooyoung, et al.
Publicado: (2019)

Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
por: Heo, Eun Jin, et al.
Publicado: (2017)

Genetic Profiles Associated with Chemoresistance in Patient-Derived Xenograft Models of Ovarian Cancer
por: Li, Lan Ying, et al.
Publicado: (2019)

Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies
por: Mendogni, Paolo, et al.
Publicado: (2022)

Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer
por: Choi, Yoon Young, et al.
Publicado: (2016)

Characterization of human cancer xenografts in humanized mice
por: Rios-Doria, Jonathan, et al.
Publicado: (2020)

Anti-Cancer Activity of As(4)O(6) and its Efficacy in a Series of Patient-Derived Xenografts for Human Cervical Cancer
por: Noh, Joseph J., et al.
Publicado: (2020)

Establishment of Human Patient-Derived Endometrial Cancer Xenografts in NOD scid Gamma Mice for the Study of Invasion and Metastasis
por: Unno, Kenji, et al.
Publicado: (2014)

Establishing Patient-Derived Cancer Cell Cultures and Xenografts in Biliary Tract Cancer
por: Kang, Jihoon, et al.
Publicado: (2023)

Fidelity of human ovarian cancer patient-derived xenografts in a partially humanized mouse model for preclinical testing of immunotherapies
por: Odunsi, Adekunle, et al.
Publicado: (2020)

Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation
por: Zuco, Valentina, et al.
Publicado: (2021)

Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models
por: Eoh, Kyung Jin, et al.
Publicado: (2018)

Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenografts
por: Kanikarla Marie, Preeti, et al.
Publicado: (2022)

Establishment of chemosensitivity tests in triple-negative and BRCA-mutated breast cancer patient-derived xenograft models
por: Park, Hyung Seok, et al.
Publicado: (2019)

Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models
por: Shin, Ha-Yeon, et al.
Publicado: (2022)

Failure of a patient-derived xenograft for brain tumor model prepared by implantation of tissue fragments
por: Kim, Kyung-Min, et al.
Publicado: (2016)

Generation and molecular characterization of pancreatic cancer patient-derived xenografts reveals their heterologous nature
por: Jung, Jaeyun, et al.
Publicado: (2016)

Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy
por: Kim, Seongyeong, et al.
Publicado: (2021)

Establishment of patient-derived cancer xenografts in immunodeficient NOG mice
por: CHIJIWA, TSUYOSHI, et al.
Publicado: (2015)

T lymphocytes derived from human cord blood provide effective antitumor immunotherapy against a human tumor
por: Lee, Yong-Soo, et al.
Publicado: (2011)

Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy
por: Zhao, Yue, et al.
Publicado: (2018)

Genomic Profiling of Patient-Derived Colon Cancer Xenograft Models
por: Lee, Won-Suk, et al.
Publicado: (2014)

Retrospective growth kinetics and radiosensitivity analysis of various human xenograft models
por: Lee, Ji Young, et al.
Publicado: (2016)

Mice transgenic for human CTLA4-CD28 fusion gene show proliferation and transformation of ATLL-like and AITL-like T cells
por: Lee, Gyu Jin, et al.
Publicado: (2022)

Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy
por: Zhang, Wei, et al.
Publicado: (2023)

Fluid Shear Stress Regulates the Landscape of microRNAs in Endothelial Cell-Derived Small Extracellular Vesicles and Modulates the Function of Endothelial Cells
por: Chung, Jihwa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gfau4oa23dkasco2roouij1ifs